Home » Newsletters » BioWorld Science

BioWorld Science

April 9, 2010

View Archived Issues

CD34 marker suggests sunitinib targets tumor vasculature in clear cell renal cell carcinoma

Eosinophil cationic protein identified as new biomarker for coronary artery disease

New dipeptidyl peptidase 4 inhibitors discovered by Cadila Pharmaceuticals

New nonopioid analgesics claimed by Elder Pharmaceuticals

Arena Pharmaceuticals and Merck & Co. claim new GPR81 agonists

Preclinical pharmacology of Lexicon Pharmaceuticals' S1PL inhibitors described

Merck & Co. selects new lead NK1 antagonist for further evaluation

Leptin therapy proves advantageous in mouse model of type 1 diabetes

Merck & Co.'s new BB3 agonist reduces weight in obesity model

Achaogen discloses novel carbacephems

New mitochondrial F1F0 ATPase hydrolase inhibitors claimed by U.S. scientists

AnaptysBio collaborates with VLST to generate novel antibody therapeutics

Health Canada approves Seasonique contraceptive

Tioga receives SPA agreement from FDA for phase III asimadoline trials in D-IBS

Seattle Genetics, Takeda and Millennium begin phase III trial of brentuximab vedotin

Crucell and GSK collaborate to develop second-generation malaria vaccine

Inovio completes enrollment in phase I VGX-3100 cervical cancer vaccine trial

MAP Pharmaceuticals begins pharmacodynamics trial of Levadex migraine therapy

Swedish Orphan Biovitrum and LFB launch Willfact in Germany for von Willebrand's disease

Sanofi-aventis obtains exclusive worldwide license for new regenerative diabetes therapeutic

King Pharmaceuticals begins phase IIb Eladur trial in chronic low back pain

FDA to review Abbott's diagnostic test for acute kidney injury risk

Hemispherx Biopharma to study Alferon N Injection for hospitalized influenza patients

Calistoga begins phase I combination trial of CAL-101 in non-Hodgkin's lymphoma and leukemia

CytRx begins phase II bafetinib trial in advanced prostate cancer

Synairgen starts phase II trial of inhaled IFN-beta in asthma caused by respiratory viruses

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...